ASE360

COVID-19 Preparedness for Echo Labs: Insights from the Frontlines

COVID-19 Pandemic: Your Questions Answered

Pediatric, Fetal, and Congenital Heart Disease Statement on COVID-19

Sonographer Statement on COVID-19

Perioperative/Periprocedural TEE Statement on COVID-19

POCUS Statement on COVID-19

ASE Statement on the Reintroduction of Echo Services During COVID-19

How to do TTE for patients with confirmed or suspected COVID-19 infection

How to do TEE for patients with confirmed or suspected COVID-19 infection

COVID-19 articles in June JASE Podcast

Ultrasound Enhancing Agents In The COVID 19 Era Protocols, Safety, and Impact With Q and A

Multisystem Inflammatory Syndrome in Children in setting of COVID-19: Clinical and Imaging Update

Recommendations for Multimodality Assessment of Congenital Coronary Anomalies

Stirring Debates Planned at the Inaugural Echo in PCHD Virtual Experience

Joint Echo Conference: Quantification of Mitral Regurgitation

Joint Echo Conference: Aortic Stenosis

Echocardiography is Key in Diagnosing Cardiac Amyloid from ASE

ASE Guideline: Recommendations for the Use of Echo in the Evaluation of Rheumatic Heart Disease

How to Assess Systolic Function with Echocardiography in Patients with HCM

ESIE LVA

ASE Guidelines for Native Valvular Regurgitation Webinar

Recommendations for the Adult Cardiac Sonographer Performing Echo to Screen for C-CHD in the Newborn

Vera H. Rigolin, MD, FASE, ASE President 2017-2018